Literature DB >> 27587279

OPA1 functionally interacts with MIC60 but is dispensable for crista junction formation.

Miguel Barrera1, Sebastian Koob1, Daniel Dikov1, Frank Vogel2, Andreas S Reichert3,4.   

Abstract

Remodeling of crista junctions (CJs) is observed in numerous human disorders and during apoptosis. The functional interplay of OPA1 and MIC60, two key players in this context, is unclear. We show that OPA1 modulates cristae morphology but is dispensable for CJ formation. MIC60 is strongly enriched at CJs, whereas OPA1 is distributed evenly across the inner membrane. MIC60 levels are increased in OPA1-/- cells which show increased cellular resistance to apoptosis induction. Endogenous OPA1 and MIC60 show a physical interaction. Overall, we suggest that the regulation of CJ remodeling during apoptosis is mediated via an interplay between OPA1 and MIC60.
© 2016 Federation of European Biochemical Societies.

Entities:  

Keywords:  MICOS; Mitofilin; apoptosis; crista junction; mitochondria

Mesh:

Substances:

Year:  2016        PMID: 27587279     DOI: 10.1002/1873-3468.12384

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  26 in total

Review 1.  Maternally inherited mitochondrial respiratory disorders: from pathogenetic principles to therapeutic implications.

Authors:  Martine Uittenbogaard; Anne Chiaramello
Journal:  Mol Genet Metab       Date:  2020-06-27       Impact factor: 4.797

Review 2.  Recent advances in, and challenges of, designing OMA1 drug screens.

Authors:  Marcel V Alavi
Journal:  Pharmacol Res       Date:  2022-01-07       Impact factor: 7.658

Review 3.  Mitochondrial inner membrane protein, Mic60/mitofilin in mammalian organ protection.

Authors:  Yansheng Feng; Ngonidzashe B Madungwe; Jean C Bopassa
Journal:  J Cell Physiol       Date:  2018-09-14       Impact factor: 6.384

Review 4.  Mitochondrial proteins: from biogenesis to functional networks.

Authors:  Nikolaus Pfanner; Bettina Warscheid; Nils Wiedemann
Journal:  Nat Rev Mol Cell Biol       Date:  2019-05       Impact factor: 94.444

5.  The short variant of the mitochondrial dynamin OPA1 maintains mitochondrial energetics and cristae structure.

Authors:  Hakjoo Lee; Sylvia B Smith; Yisang Yoon
Journal:  J Biol Chem       Date:  2017-03-15       Impact factor: 5.157

6.  High-throughput screening for natural compound-based autophagy modulators reveals novel chemotherapeutic mode of action for arzanol.

Authors:  Jana Deitersen; Lena Berning; Fabian Stuhldreier; Sara Ceccacci; David Schlütermann; Annabelle Friedrich; Wenxian Wu; Yadong Sun; Philip Böhler; Niklas Berleth; María José Mendiburo; Sabine Seggewiß; Ruchika Anand; Andreas S Reichert; Maria Chiara Monti; Peter Proksch; Björn Stork
Journal:  Cell Death Dis       Date:  2021-05-31       Impact factor: 8.469

7.  Optic Atrophy 1 Is Epistatic to the Core MICOS Component MIC60 in Mitochondrial Cristae Shape Control.

Authors:  Christina Glytsou; Enrique Calvo; Sara Cogliati; Arpit Mehrotra; Irene Anastasia; Giovanni Rigoni; Andrea Raimondi; Norihito Shintani; Marta Loureiro; Jesùs Vazquez; Luca Pellegrini; Jose Antonio Enriquez; Luca Scorrano; Maria Eugenia Soriano
Journal:  Cell Rep       Date:  2016-12-13       Impact factor: 9.423

8.  Unacylated ghrelin prevents mitochondrial dysfunction in a model of ischemia/reperfusion liver injury.

Authors:  Alberto Rossetti; Gabriele Togliatto; Anabela P Rolo; João S Teodoro; Riccarda Granata; Ezio Ghigo; Amedeo Columbano; Carlos M Palmeira; Maria Felice Brizzi
Journal:  Cell Death Discov       Date:  2017-12-04

Review 9.  Dominant Optic Atrophy (DOA): Modeling the Kaleidoscopic Roles of OPA1 in Mitochondrial Homeostasis.

Authors:  Valentina Del Dotto; Valerio Carelli
Journal:  Front Neurol       Date:  2021-06-09       Impact factor: 4.003

10.  Regulated membrane remodeling by Mic60 controls formation of mitochondrial crista junctions.

Authors:  Manuel Hessenberger; Ralf M Zerbes; Heike Rampelt; Séverine Kunz; Audrey H Xavier; Bettina Purfürst; Hauke Lilie; Nikolaus Pfanner; Martin van der Laan; Oliver Daumke
Journal:  Nat Commun       Date:  2017-05-31       Impact factor: 14.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.